Metabiomed Co Ltd
KOSDAQ:059210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Metabiomed Co Ltd
Depreciation & Amortization
Metabiomed Co Ltd
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
Depreciation & Amortization
₩5.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Suheung Co Ltd
KRX:008490
|
Depreciation & Amortization
₩40.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
SD Biosensor Inc
KRX:137310
|
Depreciation & Amortization
₩141.7B
|
CAGR 3-Years
95%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Depreciation & Amortization
₩3.3B
|
CAGR 3-Years
36%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Depreciation & Amortization
₩5.4B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
12%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Depreciation & Amortization
₩3.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Metabiomed Co Ltd
Glance View
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.
See Also
What is Metabiomed Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
5.3B
KRW
Based on the financial report for Sep 30, 2025, Metabiomed Co Ltd's Depreciation & Amortization amounts to 5.3B KRW.
What is Metabiomed Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
5%
Over the last year, the Depreciation & Amortization growth was 16%. The average annual Depreciation & Amortization growth rates for Metabiomed Co Ltd have been 15% over the past three years , 6% over the past five years , and 5% over the past ten years .
